metformin mitochondrial damage

COVID Notes: Considering Drug Induced Mitochondrial Damage

4958 views

Much has been written about the associations between COVID severity, chronicity, and pre-existing conditions. Top among those conditions include cardiovascular disease and diabetes, likely type 2, but both are lumped together. What has not been discussed is why this would be the case. On a basic level, fighting two illnesses takes more energy than fighting one. This is obvious. What is not obvious is that many modern illnesses, especially cardiovascular disease and type 2 diabetes, begin in the mitochondria as a consequence of diet and lifestyle. Statistically, 80% of cardiovascular disease and 78-83% of type 2 diabetes can be traced back to longstanding dietary, lifestyle and environmental issues* that effectively diminish mitochondrial energetic capabilities and disrupt metabolic flexibility; and the remainder that did not originate from diet and lifestyle are certainly affected by these variables.

To function effectively and to convert the foods we eat into energy or ATP, the mitochondria require sufficient vitamins and minerals, 22 of them, in fact. Western diets, while high in calories, are woefully low in these micronutrients, even when fortified, creating what we refer to as high calorie malnutrition. Against this dietary backdrop, reduced ATP then leads to a constant, low level molecular hypoxia. This is not a hypoxia of obstruction or exertion, but more fundamental. For without proper nutrients, mitochondria can neither utilize oxygen effectively to create ATP, nor do they have sufficient ATP to traffic the O2 into the hemoglobin where it can be pumped into circulation to feed tissues and organs. It is a subtle desaturation, at least initially, but one that initiates all sorts of compensatory reactions to mitigate risk; reactions that are necessary and lifesaving in the short term but become increasingly harmful as time passes.

With insufficient ATP, inflammatory and immune reactions become disrupted and even seemingly chaotic; hormone and electrolyte regulation becomes imbalanced and organ and brain function diminishes. We get disrupted autonomic function (dysautonomia), which cycles back and further disrupts everything else. Depression, anxiety and other mental health issues are also common. This underlying mitochondrial distress is part of the reason why patients with comorbid conditions are at increased risk of not only developing but succumbing to COVID, or really, any virulent pathogen. Their mitochondria are already taxed. They are already carrying low-level hypoxia and, in a very real way, they simply do not have the energy to mount or manage a successful defense.

Now, to add insult to already injured mitochondria, we prescribe medications to manage these conditions rather than correct the root cause, which remember is mitochondrial distress. These medications, while they effectively provide the semblance of health, likely cause more damage to an already damaged system. That is, we get more normal labs, or in the case of antidepressants or anxiolytics, we may feel better, but they do nothing to correct the problem. They only exacerbate it further.

An Unappreciated Factor in COVID Severity and Chronicity

A little appreciated fact in medicine, all pharmaceuticals damage mitochondrial function by some mechanism or another. I have published extensively on this topic here on HM and in our book. Sometimes they deplete critical micronutrients and other times they directly distress, damage and/or deform the mitochondrial membrane by forcibly overriding the regulation of key enzymes involved in ATP production. This, of course, is often compounded by poor nutrition and nearly continuous exposures to chemical toxicants in the environment. It is a perfect cycle of destruction. Poor nutrition causes poorly functioning mitochondria, which decreases ATP while increasing cell level hypoxia, which then initiates inflammation and alters immune reactivity, and rather than correct this, we prescribe medications to override what are necessary reactions to poor nutrition and environmental exposures. These medications then elicit additional damage, further decreasing mitochondrial efficiency and ATP, which necessitates extra nutrients to maintain ATP and stave off more damage.

When we consider the association between COVID severity and comorbid health issues, it must be against the backdrop of nutrition and pharmaceutically and environmentally induced mitochondrial damage. The only variables we can control directly are nutrition and pharmaceutical exposures. We can add more nutrition and we can apply medications more cautiously, but more often than not, we choose to do neither. We ignore nutrient status and stack medications on top of each other endlessly, all the while wondering why the patient’s health continues to decline.

Common Drugs Block Vitamins B1, B9, B12, and CoQ10

To illustrate the state of drug-induced mitochondrial hypoxia that plague so many of the patients threatened by COVID, let us look one common medication that as of 2017, 78 million Americans were taking: metformin. Metformin damages the mitochondria by multiple mechanisms that ultimately lead to reduced ATP, entrenched molecular hypoxia, inflammatory cascades and altered immune reactivity. This, of course, is in addition to the neurological sequelae.

Perhaps the most critical nutrient for in mitochondrial health is thiamine. Thiamine, is blocked by metformin. Metformin blocks vitamin B1 – thiamine – uptake  by multiple mechanisms. When metformin is present, a set of transporters that normally bring thiamine into the cell to perform its task as a cofactor in the machinery that converts carbs to ATP, brings metformin into the cell instead, replacing thiamine altogether. The transporters involved are the SLC22A1, also called the organic cation transporter 1, [OAT1] and the SLC19A3. Metformin also blocks the lactate pathway and acetyl coenzyme A carboxylase (an enzyme necessary to process fatty acids into fuels). Thiamine is critical for mitochondrial function and its position as gateway substrate into the each the of the pathways leading to the electron transport chain, means that insufficient or deficient thiamine limits ATP production, induces cell level hypoxia and all of the inflammatory cascades that go with this process.

Metformin also depletes vitamins B12 and B9, which are responsible for hundreds of enzymatic reactions and particularly important in central nervous system function including myelination (how many cases of diabetic neuropathy or multiple sclerosis are really vitamin b12 deficiency?) One study found almost 30% of Metformin users were vitamin B12 deficient. For the US alone, that’s 26 million people who could be vitamin B12 deficient and likely do not know that they are deficient. What happens when one is B12 deficient? Inflammation increases, along with homocysteine concentrations, which is a very strong and independent risk factor for heart disease (the very same disease metformin is promoted to prevent).  What else happens when B12 is deficient? Poor iron management, better known as pernicious anemia.

Metformin tanks CoEnzyme Q10 which effectively cripples mitochondrial ATP production even further, by as much as 48% in muscles. Imagine having to function in such a reduced capacity. Now imagine having to fight a deadly virus or recover from one. Finally, if the reductions in nutrients and ATP weren’t sufficiently troubling, metformin also interferes with the body’s innate toxicant metabolism pathways, the P450 enzymes, rendering those who use this drug less capable of effectively metabolizing a whole host of other medications and environmental toxicants.

This is one medication. Very few adults who go down this pathway are prescribed just one medication. With metformin, one is likely also to have a statin, perhaps a blood pressure medicine, and if the patient is a women, some form of birth control or hormone replacement. Many are also on antidepressants or anxiolytics. Statins, for example, severely deplete CoQ10, further crippling the electron transport chain. Synthetic hormones deplete a whole host of nutrients (thiamine, riboflavin, pyridoxine, folate, vitamin B12, ascorbic  acid, and zinc) while damaging mitochondria via multiple mechanisms.

Long COVID and Medication

Just as the use of medications leading up to and during the illness impact the functioning of one’s mitochondria, the use of medications across time, as one recovers from the infection, will negatively impact mitochondrial capacity as well. This, of course, is in addition to the demand COVID itself places on mitochondrial energy capacity. Data suggests that at least 10% and upwards of 80% of COVID survivors have lingering symptoms. Among the most common are fatigue, brain fog, muscle pain and weakness, and breathing difficulties along with an array of dysautonomias.  These are classical indicators of ailing mitochondria and yet common treatment protocols involve more of the same medications and none of the nutrients needed to support them. As we go forward and recover from the COVID pandemic, I think it is incumbent upon us to look at mitochondrial health more closely.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

*Environmental issues should be considered as the totality of chemical exposures from environmental, agricultural, industrial, and pharmaceutical sources. Environmental exposures damage mitochondria and should not be excluded as contributing factors to illness.

Stop the Metformin Madness

28915 views

I have never been a fan of Metformin. It seemed too good to be true. Many years ago I had a conversation with a researcher about all of its possible therapeutic indications. His lab was actively pursuing the anti-cancer angle. That should have been a clue that Metformin might be causing more damage than we recognized, but it wasn’t. At that point, I was still enamored with the wonders of pharmacology and hadn’t yet begun my path toward understanding medication adverse reactions. Indeed, it wasn’t until very recently, when a family member began suffering from one of these reactions, that I began my investigation in full. This is what I learned.

Type 2 Diabetes is Big Business

The global profits from Type 2 diabetes medications rested at a paltry 23 billion dollars in 2011 but are expected to grow to over $45 billion annually by 2020. The market growth is bolstered in large part by the ever-expanding demand for therapeutics like Metformin or Glucophage. Metformin is the first line of treatment and standard of care for insulin resistance across all populations of Type 2 diabetics with over 49 million Americans on Metformin in 2011-2012. It is particularly popular in women’s health with an increasing reliance on Metformin for the metabolic dysfunction observed in women with PCOS, PCOS-related infertility, and even gestational diabetes. Metformin is prescribed so frequently and considered so innocuous that it is sometimes euphemistically referred to as vitamin M.

If we quickly scan the safety research for metformin, there is little immediate evidence suggesting any side effects whatsoever. In fact, in addition to controlling blood sugar by blocking the hepatic glucose dump, this drug is suggested to promote weight loss, increase ovulation in women, (thereby helping achieve pregnancy), and prevent an array of pregnancy complications (everything from miscarriage to gestational diabetes, pre-eclampsia and preterm birth). Metformin is argued to prevent cancer and the neurocognitive declines associated with aging, even aging itself. By all accounts, Metformin is a wonder drug. Why isn’t everyone on Metformin prophylactically? Increasingly, we are.

With the increasing rates of obesity and associated metabolic disturbances, drugs that purportedly reduce those indicators are primed for growth. Like the push to expand statin prescription rates from 1 in 4 Americans to perhaps 1 in 3, millions have been spent increasing the therapeutic indications and reach for this medication. Amid all the excitement over this drug, one has to wonder if it isn’t too good to be true. In our exuberance to get something for nothing, to have cake, if you will, have we overlooked the very real risks and side effects associated with Metformin?  I think we have.

Metformin and Vitamin B12 Deficiency

As we’ve reported previously, Metformin leaches vitamin B12 and to a lesser degree B9 (folate) from the body. One study found almost 30% of Metformin users are vitamin B12 deficient. For the US alone, that’s almost 15 million people who could be vitamin B12 deficient and likely do not know that they are deficient. What happens when one is vitamin B12 deficient?

Firstly, inflammation increases, along with homocysteine concentrations, which is a very strong and independent risk factor for heart disease (the very same disease Metformin is promoted to prevent).  And that is the tip of the iceberg.

Vitamin B12 is involved with a staggering number of physiological functions including DNA, RNA, hormone, lipid, and protein synthesis. Deplete vitamin B12 and a whole host of problems emerge, mostly neurological.

Vitamin B12 is critical for the synthesis of the myelin sheaths around nerve fibers. There is a growing relationship between multiple sclerosis, which involves the disintegration of myelin and brain white matter, and vitamin B12 deficiency.  Often the first signs of B12 deficiency are nervous system-related with cognitive disturbances and peripheral neuropathy among the most common.

Additionally, many women have dysregulated hormones connected to vitamin B12 deficiency. In light of the Metformin-mediated vitamin B12 deficiency, one has to wonder if some of the chronic health issues plaguing modern culture are not simply iatrogenic or medication-induced.

Metformin, Pregnancy and Maternal and Fetal Complications

Considering that half the population is female, many of whom are on Metformin and may become pregnant, we must consider the potential effects of Metformin-induced vitamin B12 deficiency during pregnancy. As troubling as the effects of B12 deficiency are on non-pregnant individuals, during pregnancy they can be devastating. Vitamin B12 deficiency during pregnancy leads to an increased incidence of neural tube defects and anencephaly (the neural tube fails to close during gestation). Once thought to be solely related to folate deficiency (vitamin B9) which Metformin also induces, researchers are now finding that B12 has a role in neural tube defects as well.

Scan the internet for Metformin and infertility and you’ll see long lists of fertility centers boasting the benefits of this drug. During pregnancy, the exuberance for vitamin M is palpable, although entirely misplaced. Early reports suggested Metformin would reduce an array of pregnancy complications including gestational diabetes. The data supporting these practices were mixed at best. At worst, however, they were downright incorrect. Metformin, it appears, may evoke the very conditions it was promoted to prevent during pregnancy and then some. Additionally, recent research suggests Metformin alters fetal development and induces long-term metabolic changes in the offspring, likely predisposing the children to Type 2 Diabetes, an epigenetic effect perhaps.

Metformin Inhibits Exercise-Induced Insulin Sensitivity

As if those side effects were not enough to question mass Metformin prescribing practices, it appears that Metformin reduces any gains in insulin sensitivity that normally would be achieved from exercise. I cannot help but wonder if Metformin impairs insulin signaling in general. Cancer research suggests that it might.

According to one study, physical exercise can increase insulin sensitivity by up to 54% in insulin-resistant individuals, unless of course, they are taking Metformin. Metformin abolishes any increased insulin sensitivity gained by exercise. Metformin also reduces peak aerobic capacity, reducing performance and making exercise more difficult. Moreover, despite claims to the contrary, Metformin does not appear to be an especially effective tool for weight loss, netting a reduction of only 5-10 pounds over 4-8 months. Regular exercise and a healthy diet net on average a loss of 5-10 pounds per month for most people and are significantly more effective at reducing diabetes and associated health complications without the potential side effects.

Metformin and Mitochondrial Damage

Perhaps most troubling amongst the Metformin side effects is its ability to severely impair mitochondrial functioning.

Recall from high school biology, the mitochondria are those bean-shaped organelles inside cells that are responsible for cellular respiration or energy production. Through a variety of pathways, the mitochondria provide fuel for cell survival. In addition to cellular energy production, mitochondria control cell apoptosis (death), calcium, copper, and iron homeostasis, and steroidogenesis. In essence, mitochondria perform the key tasks associated with cell survival, and indeed, human survival. Damage the mitochondria and cellular dysfunction or death will occur. Damage sufficient numbers of mitochondrion and chronic, multi-symptom illness arises.

As we have come to learn, many pharmaceuticals, environmental toxicants, and even dietary deficiencies can impair mitochondrial functioning and induce disease processes that are often difficult to diagnose and treat. Metformin is no different. Metformin impairs mitochondrial functioning quite significantly by several mechanisms and, in doing so, sets off a cascading sequence of ill effects.

At the center of metformin’s mitochondrial damage is its effect on the most basic of mitochondrial functions – ATP (cellular energy) production. Metformin reduces mitochondrial ATP production in skeletal muscle by as much as 48%. Sit with that one for a moment, a 48% reduction in cell fuel. Imagine functioning at only half capacity. This would make basic activities difficult at best and exercising to lose weight a very unlikely proposition. Imagine similar reductions in ATP production were observed in the brain or the heart or the GI tract (which, when on Metformin are likely), the types of disturbances we might see become quite clear: neurocognitive decline, psychiatric instability, neuropathy, heart rate, rhythm and blood pressure abnormalities, along with gastrointestinal distress to name but a few. Underlying all of these symptoms, and indeed, all mitochondrial dysfunction is an overwhelming sense of fatigue and malaise.

Metformin Alters Immune Reactivity via the Mitochondria

As I wrote in a previous post:

Some researchers argue that the mitochondria are the danger sensors for host organisms; having evolved over two billion years to identify and communicate signs of danger to the cells within which they reside. The signaling is simple and yet highly refined, involving a series of switches that control cellular energy, and thus, cellular life or death. When danger is present, energy resources are conserved and the immune system fighters are unleashed. When danger is resolved, normal functioning can resume.

If the danger is not resolved and the immune battles must rage on, the mitochondria begin the complicated process of reallocating resources until the battle is won or the decision is made to institute what can only be described as suicide – cell death. Cell death is a normal occurrence in the cell cycle of life. Cells are born and die for all manner of reasons. But when cell death occurs from mitochondrial injury, it is messy, and evokes even broader immune responses, setting a cascade in motion that is difficult to arrest.

Metformin alters this process, first by damaging the mitochondrial ATP factory and reducing energy production capacity and then by inhibiting the signaling cascades that would normally respond to the danger signals. The double hit fundamentally alters immune function and I would suspect predisposes those who take Metformin to more infections and an array of inflammation-based disease processes. More details on this in a subsequent post.

Metformin and the Statins: Beware

The mechanisms through which Metformin derails mitochondrial functioning are complex but likely related to depletion of coQ10, an enzyme involved in what is called the electron transport chain within the mitochondria. CoQ10 also referred to as ubiquinol and ubiquinone, is critical for mitochondrial functioning. Recall from a previous post, that statins, like Lipitor, Crestor and others also deplete coQ10 and from a pharmacological perspective these mechanisms are implicated in the development of atherosclerosis and heart failure.

“statins may be causative in coronary artery calcification and can function as mitochondrial toxins that impair muscle function in the heart and blood vessels through the depletion of coenzyme Q10 and ‘heme A’, and thereby ATP generation.”

CoQ10 depletion is also implicated in the more common statin-induced side effects like muscle pain and weakness and in severe cases, rhabdomyolysis. Since Metformin and statins are regularly co-prescribed, the potential for severely depleted mitochondria and significant side effects is very high. Consider muscle pain and weakness among the first signs of problems.

My Two Cents

When we contrast the reduction in glucose mediated by Metformin with the damage this medication does to the mitochondria and immune signaling, along with its ability to leach vitamin B12, block insulin sensitivity and reduce aerobic capacity, one cannot help but wonder if we are causing more harm than good. Admittedly, obesity and hyperglycemia are growing problems in Western cultures. As we are coming to learn, however, obesity itself is not linked to the diseases processes for which many drugs like statins and Metformin are promoted to protect against – the obesity paradox. Growing evidence suggests that obesity is indicative of mitochondrial dysfunction and chemical exposures which then may provoke impaired insulin sensitivity and hyperglycemia and continued fat storage versus metabolism. If this is true, simply reducing circulating glucose concentrations, in an effort to reduce obesity and the purported health problems associated with obesity, will do nothing to treat the underlying problem.

Insulin resistance and the associated hyperglycemia are environmental and lifestyle-mediated problems that should be reversible with environmental and lifestyle changes. Having said that, those lifestyle and dietary changes will fail unless we consider the underlying mitochondrial damage initiated by dietary choices, pharmaceuticals, and other environmental exposures. For that, we must dig deeper into mitochondrial functioning and correct what we can.

I believe obesity and hyperglycemia are symptoms of damaged and dysfunctional mitochondria, partly mediated by lifestyle, partly iatrogenic (pharmaceutically induced), and likely epigenetic. If we are to solve the ‘obesity’ problem and prevent the damage mediated by hyperglycemia, we have to address these variables. Failing to do so serves no one except those who profit from our continued ill-health.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, and like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter.